John J. Toole is SVP & Clinical Research at GILEAD SCIENCES INC (GILD). They have made 6 open-market trades across 1 company since 2006, most recently 2007-04-25.
CIK 0001258445
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GILD | 19,148 | $3.0M |
Shares reported on the most recent Form 4, priced at the 2007-04-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GILD | SELL | 2007-04-25 | 2007-04-26 | $83.08 | $1.6M | -7.2% | -1.8% | -1.8% |
| GILD | SELL | 2007-02-23 | 2007-02-27 | $73.27 | $1.5M | -7.2% | -1.8% | -1.8% |
| GILD | SELL | 2006-11-17 | 2006-11-21 | $68.95 | $2.5M | -7.2% | -1.8% | -1.8% |
| GILD | SELL | 2006-08-16 | 2006-08-18 | $63.69 | $3.2M | -7.2% | -1.8% | -1.8% |
| GILD | SELL | 2006-08-16 | 2006-08-18 | $63.70 | $104K | -7.2% | -1.8% | -1.8% |
| GILD | SELL | 2006-02-09 | 2006-02-13 | $59.34 | $2.1M | -7.2% | -1.8% | -1.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.